Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

NCT03359746 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir/Elbasvir

Sponsor

King Faisal Specialist Hospital & Research Center

Collaborators

[object Object]